These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Macanovic M; Sinicropi D; Shak S; Baughman S; Thiru S; Lachmann PJ Clin Exp Immunol; 1996 Nov; 106(2):243-52. PubMed ID: 8918569 [TBL] [Abstract][Full Text] [Related]
4. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132 [TBL] [Abstract][Full Text] [Related]
6. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus. Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. Nezlin R; Alarcón-Segovia D; Shoenfeld Y J Autoimmun; 1998 Oct; 11(5):489-93. PubMed ID: 9802934 [TBL] [Abstract][Full Text] [Related]
8. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC; Ho LY; Leung HW; Wong LG Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493 [TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. Nydegger UE; Lambert PH; Gerber H; Miescher PA J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384 [TBL] [Abstract][Full Text] [Related]
11. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
12. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus. Khan MA; Dixit K; Moinuddin ; Arif Z; Alam K Biochimie; 2014 Feb; 97():104-13. PubMed ID: 24113317 [TBL] [Abstract][Full Text] [Related]
13. Anti-DNA antibodies and circulating immune complexes in systemic lupus erythematosus. Phanichphant S; Petchclai B; Tanakitikul N J Med Assoc Thai; 1982 Jan; 65(1):18-22. PubMed ID: 6153036 [No Abstract] [Full Text] [Related]
14. Systemic Lupus Erythematosus and DNA Degradation and Elimination Defects. Arneth B Front Immunol; 2019; 10():1697. PubMed ID: 31440232 [No Abstract] [Full Text] [Related]
15. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report. Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738 [TBL] [Abstract][Full Text] [Related]
16. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice. Chuan W; Wu-qing W; Zhu-wen Y; Zuo L Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437 [TBL] [Abstract][Full Text] [Related]
18. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750 [TBL] [Abstract][Full Text] [Related]
19. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. Raz E; Brezis M; Rosenmann E; Eilat D J Immunol; 1989 May; 142(9):3076-82. PubMed ID: 2785132 [TBL] [Abstract][Full Text] [Related]
20. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]